Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Delayed interval delivery in multiple gestations: the Munich experience.
Kolben T, Fischer D, Ruehl I, Franz M, Hester A, Kolben TM, Deppe C, Delius M, Friese K, Mahner S, Hasbargen U, Hübener C. Kolben T, et al. Among authors: hester a. Arch Gynecol Obstet. 2019 Feb;299(2):339-344. doi: 10.1007/s00404-018-4959-2. Epub 2018 Nov 1. Arch Gynecol Obstet. 2019. PMID: 30386991
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer.
Rhiem K, Zachariae S, Waha A, Grill S, Hester A, Golatta M, van Mackelenbergh M, Fehm T, Schlaiß T, Ripperger T, Ledig S, Meisel C, Speiser D, Veselinovic K, Schröder C, Witzel I, Gallwas J, Weber BHF, Solbach C, Aktas B, Hahnen E, Engel C, Schmutzler R. Rhiem K, et al. Among authors: hester a. Breast Care (Basel). 2023 May;18(2):106-112. doi: 10.1159/000528972. Epub 2023 Jan 6. Breast Care (Basel). 2023. PMID: 37261134 Free PMC article.
Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer.
Kahlert S, Kolben TM, Schmoeckel E, Czogalla B, Hester A, Degenhardt T, Kempf C, Mahner S, Harbeck N, Kolben T. Kahlert S, et al. Among authors: hester a. Eur J Surg Oncol. 2018 Sep;44(9):1318-1323. doi: 10.1016/j.ejso.2018.06.014. Epub 2018 Jun 23. Eur J Surg Oncol. 2018. PMID: 30041974
The role of EP3-receptor expression in cervical dysplasia.
Hester A, Ritzer M, Kuhn C, Schmoeckel E, Mayr D, Kolben T, Dannecker C, Mahner S, Jeschke U, Kolben TM. Hester A, et al. J Cancer Res Clin Oncol. 2019 Feb;145(2):313-319. doi: 10.1007/s00432-018-2785-3. Epub 2018 Nov 7. J Cancer Res Clin Oncol. 2019. PMID: 30402741
Involvement of ILR4α and TLR4 in miscarriages.
Kolben TM, Rogatsch E, Hester A, Kuhn C, Schmoeckel E, Czogalla B, Mahner S, Jeschke U, Kolben T. Kolben TM, et al. Among authors: hester a. J Reprod Immunol. 2019 Feb;131:36-43. doi: 10.1016/j.jri.2018.12.001. Epub 2019 Jan 8. J Reprod Immunol. 2019. PMID: 30639993 Clinical Trial.
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.
Czogalla B, Kuhn C, Heublein S, Schmöckel E, Mayr D, Kolben T, Trillsch F, Burges A, Mahner S, Jeschke U, Hester A. Czogalla B, et al. Among authors: hester a. J Cancer Res Clin Oncol. 2019 Oct;145(10):2519-2527. doi: 10.1007/s00432-019-03017-8. Epub 2019 Sep 4. J Cancer Res Clin Oncol. 2019. PMID: 31485769
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology.
Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Hester A, Zeder-Göß C, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Czogalla B, et al. Among authors: hester a. Cancer Manag Res. 2019 Aug 14;11:7673-7684. doi: 10.2147/CMAR.S210004. eCollection 2019. Cancer Manag Res. 2019. PMID: 31616183 Free PMC article.
144 results